Abstract
Gliomas are one of the most prevalent brain tumors. This study sought to elucidate the mechanism of CUX2 in glioma development via ADCY1. CUX2 and ADCY1 expression in glioma predicted by bioinformatics analysis. Subsequent to gain- and loss-of-function experiments in glioma cells, cell proliferation was tested by CCK8 and plate clone formation assays, and cell migration and invasion by Transwell assay. The binding between CUX2 and ADCY1 was examined with dual-luciferase gene reporter and ChIP assays. The xenograft mouse model was established to verify the effect of the CUX2/ADCY1 axis on glioma cell growth in vivo. CUX2 and ADCY1 expression was low in glioma. The overexpression of CUX2 repressed the proliferative, migrating, and invasive abilities of glioma cells. Moreover, CUX2 was enriched in the ADCY1 promoter to enhance ADCY1 expression. ADCY1 upregulation diminished glioma cell proliferative, migrating, and invasive properties. Silencing of ADCY1 abrogated and upregulation of ADCY1 promoted the inhibitory influence of CUX2 upregulation on the malignant behaviors of glioma cells in vitro and gliomas cell growth in vivo. Collectively, CUX2 promoted ADCY1 transcription to delay glioma cell migration, proliferation, and invasion.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Availability of data and materials
The datasets used or analyzed during the current study are available from the corresponding author upon reasonable request.
References
Chatron N, Moller RS, Champaigne NL et al (2018) The epilepsy phenotypic spectrum associated with a recurrent CUX2 variant. Ann Neurol 83:926–934. https://doi.org/10.1002/ana.25222
Eslahi M, Dana PM, Asemi Z, Hallajzadeh J, Mansournia MA, Yousefi B (2021) The effects of chitosan-based materials on glioma: Recent advances in its applications for diagnosis and treatment. Int J Biol Macromol 168:124–129. https://doi.org/10.1016/j.ijbiomac.2020.11.180
Hua Y, Ma X, Liu X, Yuan X, Qin H, Zhang X (2017) Identification of the potential biomarkers for the metastasis of rectal adenocarcinoma. APMIS 125:93–100. https://doi.org/10.1111/apm.12633
IJzerman-Korevaar M, Snijders TJ, de Graeff A, Teunissen S, de Vos FYF (2018) Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review. J Neurooncol 140:485–496. https://doi.org/10.1007/s11060-018-03015-9
Kaluzinska Z, Kolat D, Bednarek AK, Pluciennik E (2021) PLEK2, RRM2, GCSH: a novel WWOX-dependent biomarker triad of glioblastoma at the crossroads of cytoskeleton reorganization and metabolism alterations. Cancers (basel). https://doi.org/10.3390/cancers13122955
Li Y, Liang Q, Wen YQ et al (2010) Comparative proteomics analysis of human osteosarcomas and benign tumor of bone. Cancer Genet Cytogenet 198:97–106. https://doi.org/10.1016/j.cancergencyto.2010.01.003
Liu G, Zhao H, Song Q, Li G, Lin S, Xiong S (2021) Long non-coding RNA DPP10-AS1 exerts anti-tumor effects on colon cancer via the upregulation of ADCY1 by regulating microRNA-127-3p. Aging (albany NY) 13:9748–9765. https://doi.org/10.18632/aging.202729
Lubker C, Urbauer RJ, Moskovitz J et al (2015) Membranous adenylyl cyclase 1 activation is regulated by oxidation of N- and C-terminal methionine residues in calmodulin. Biochem Pharmacol 93:196–209. https://doi.org/10.1016/j.bcp.2014.11.007
Ludwig K, Kornblum HI (2017) Molecular markers in glioma. J Neurooncol 134:505–512. https://doi.org/10.1007/s11060-017-2379-y
Pal R, Ramdzan ZM, Kaur S et al (2015) CUX2 protein functions as an accessory factor in the repair of oxidative DNA damage. J Biol Chem 290:22520–22531. https://doi.org/10.1074/jbc.M115.651042
Peng Z, Liu C, Wu M (2018) New insights into long noncoding RNAs and their roles in glioma. Mol Cancer 17:61. https://doi.org/10.1186/s12943-018-0812-2
Poff A, Koutnik AP, Egan KM, Sahebjam S, D’Agostino D, Kumar NB (2019) Targeting the Warburg effect for cancer treatment: ketogenic diets for management of glioma. Semin Cancer Biol 56:135–148. https://doi.org/10.1016/j.semcancer.2017.12.011
Reuss AM, Groos D, Buchfelder M, Savaskan N (2021) The acidic brain-glycolytic switch in the microenvironment of malignant glioma. Int J Mol Sci. https://doi.org/10.3390/ijms22115518
Weiss LA, Nieto M (2019) The crux of Cux genes in neuronal function and plasticity. Brain Res 1705:32–42. https://doi.org/10.1016/j.brainres.2018.02.044
Wittmann W, Iulianella A, Gunhaga L (2014) Cux2 acts as a critical regulator for neurogenesis in the olfactory epithelium of vertebrates. Dev Biol 388:35–47. https://doi.org/10.1016/j.ydbio.2014.01.026
Xu S, Tang L, Li X, Fan F, Liu Z (2020) Immunotherapy for glioma: current management and future application. Cancer Lett 476:1–12. https://doi.org/10.1016/j.canlet.2020.02.002
Yang H, Kim J, Kim Y, Jang SW, Sestan N, Shim S (2020a) Cux2 expression regulated by Lhx2 in the upper layer neurons of the developing cortex. Biochem Biophys Res Commun 521:874–879. https://doi.org/10.1016/j.bbrc.2019.11.004
Yang M, Ding Q, Zhang M, Moon C, Wang H (2020b) Forebrain overexpression of type 1 adenylyl cyclase promotes molecular stability and behavioral resilience to physical stress. Neurobiol Stress 13:100237. https://doi.org/10.1016/j.ynstr.2020.100237
Yang K, Wu Z, Zhang H et al (2022) Glioma targeted therapy: insight into future of molecular approaches. Mol Cancer 21:39. https://doi.org/10.1186/s12943-022-01513-z
Zeng J, Li X, Sander M, Zhang H, Yan G, Lin Y (2021) Oncolytic viro-immunotherapy: an emerging option in the treatment of gliomas. Front Immunol 12:721830. https://doi.org/10.3389/fimmu.2021.721830
Zhang Y, Yang J, Wang X, Li X (2021) GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses. Sci Rep 11:20441. https://doi.org/10.1038/s41598-021-99544-x
Zou T, Liu J, She L et al (2019) A perspective profile of ADCY1 in cAMP signaling with drug-resistance in lung cancer. J Cancer 10:6848–6857. https://doi.org/10.7150/jca.36614
Acknowledgements
Thanks to all the contributors.
Author information
Authors and Affiliations
Contributions
LD conceived the ideas. LD designed the experiments. GY performed the experiments. SL analyzed the data. SM and ZG provided critical materials. SL and CC wrote the manuscript. LD supervised the study. All the authors have read and approved the final version for publication.
Corresponding author
Ethics declarations
Conflict of interest
The authors report no relationships that could be construed as a conflict of interest.
Additional information
Communicated by Sreedharan Sajikumar.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yao, G., Le, S., Min, S. et al. CUX2 prevents the malignant progression of gliomas by enhancing ADCY1 transcription. Exp Brain Res 240, 3153–3165 (2022). https://doi.org/10.1007/s00221-022-06481-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00221-022-06481-w